Na Luo Selected Research

Intercellular Adhesion Molecule-3

1/2020	Aspirin mediates histone methylation that inhibits inflammation-related stemness gene expression to diminish cancer stemness via COX-independent manner.
1/2020	Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner.
8/2018	ICAM3 mediates tumor metastasis via a LFA-1-ICAM3-ERM dependent manner.
1/2018	ICAM3 mediates inflammatory signaling to promote cancer cell stemness.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Na Luo Research Topics

Disease

43	Neoplasms (Cancer) 08/2022 - 04/2011
24	Breast Neoplasms (Breast Cancer) 08/2022 - 10/2012
9	Neoplasm Metastasis (Metastasis) 05/2022 - 07/2017
9	Inflammation (Inflammations) 01/2021 - 01/2014
5	Triple Negative Breast Neoplasms 10/2021 - 04/2016
4	Carcinogenesis 10/2021 - 05/2018
4	Lung Neoplasms (Lung Cancer) 12/2020 - 06/2015
3	Schizophrenia (Dementia Praecox) 01/2022 - 07/2018
3	Melanoma (Melanoma, Malignant) 10/2021 - 01/2018
3	Carcinoma (Carcinomatosis) 10/2021 - 04/2011
3	Obesity 10/2020 - 02/2011
3	Oculocerebrorenal Syndrome (Lowe Syndrome) 10/2017 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 06/2013 - 04/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2012
2	Hypertension (High Blood Pressure) 06/2021 - 08/2011
2	Type 2 Diabetes Mellitus (MODY) 03/2021 - 05/2006
2	Glioma (Gliomas) 01/2021 - 01/2018
2	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2019 - 01/2019
2	Pathologic Processes 03/2019 - 01/2019
2	Glaucoma 01/2017 - 01/2013
2	Insulin Resistance 01/2017 - 05/2006
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2016 - 01/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2014 - 02/2014
2	Dyslipidemias (Dyslipidemia) 08/2011 - 02/2011
2	Non-alcoholic Fatty Liver Disease 08/2011 - 02/2011
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2022
1	Colorectal Neoplasms (Colorectal Cancer) 05/2022
1	Stomach Neoplasms (Stomach Cancer) 05/2022
1	Lymphatic Metastasis 05/2022
1	Leukemia 01/2022
1	Adenocarcinoma 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Contracture 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Stroke (Strokes) 01/2022

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 08/2022 - 09/2021
6	Proteins (Proteins, Gene)FDA Link 05/2022 - 06/2013
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2014
5	CateninsIBA 10/2021 - 02/2014
5	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 08/2011
4	Messenger RNA (mRNA)IBA 05/2022 - 04/2011
4	Biological ProductsIBA 05/2022 - 01/2014
4	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2018
4	Intercellular Adhesion Molecule-3IBA 01/2020 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 03/2018 - 12/2012
4	Inositol Polyphosphate 5-PhosphatasesIBA 10/2017 - 12/2012
3	CholesterolIBA 03/2022 - 01/2018
3	EnzymesIBA 01/2022 - 04/2017
3	MethyltransferasesIBA 01/2022 - 01/2018
3	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 09/2015
3	MicroRNAs (MicroRNA)IBA 01/2020 - 03/2012
3	Peptides (Polypeptides)IBA 05/2018 - 03/2011
3	MicellesIBA 05/2018 - 05/2015
2	Ursolic AcidIBA 01/2022 - 12/2020
2	Hormones (Hormone)IBA 10/2021 - 09/2021
2	InterferonsIBA 08/2021 - 01/2018
2	Interferon-gamma (Interferon, gamma)IBA 01/2021 - 01/2018
2	Long Noncoding RNAIBA 10/2020 - 10/2018
2	Histones (Histone)IBA 01/2020 - 01/2020
2	Phenobarbital (Luminal)FDA Link 01/2020 - 06/2015
2	CytokinesIBA 01/2019 - 01/2014
2	ChemokinesIBA 01/2019 - 03/2018
2	VaccinesIBA 05/2018 - 09/2016
2	LigandsIBA 03/2018 - 01/2018
2	guadecitabineIBA 03/2018 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2018 - 06/2015
2	CaspasesIBA 04/2017 - 07/2015
2	Inosine Triphosphate (ITP)IBA 10/2016 - 01/2016
2	Insulin (Novolin)FDA Link 10/2012 - 05/2006
2	Transcription Factors (Transcription Factor)IBA 03/2012 - 01/2008
2	ORALIT (ORS)IBA 08/2011 - 02/2011
2	Leptin ReceptorsIBA 03/2011 - 05/2006
2	LeptinIBA 03/2011 - 05/2006
1	Butyric Acid (Butanoic Acid)IBA 08/2022
1	norvalineIBA 08/2022
1	Glucuronic Acid (Glucuronate)IBA 08/2022
1	isobutyric acidIBA 08/2022
1	AcidsIBA 08/2022
1	Acetic Acid (Vinegar)FDA LinkGeneric 08/2022
1	KinesinsIBA 05/2022
1	Serotonin ReceptorsIBA 01/2022
1	Decitabine FDA Link 01/2022
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2022
1	KynurenineIBA 01/2022
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022
1	Pentacyclic TriterpenesIBA 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022

Therapy/Procedure

16	Therapeutics 01/2022 - 10/2012
7	Immunotherapy 03/2022 - 01/2018
6	Drug Therapy (Chemotherapy) 01/2021 - 06/2013
2	Neoadjuvant Therapy 10/2021 - 06/2015
1	Electrodes (Electrode) 01/2022